This mechanism underscores the therapeutic potential of targeting the PADIs/NLRP3/Ym1 axis in sepsis treatment, offering a promising strategy for treating patient with sepsis and/or other related inflammatory disorders. Here, NLRP3 is linked to Sepsis.